Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2008
11/13/2008US20080280951 Salt Il
11/13/2008US20080280949 Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators
11/13/2008US20080280941 8-Phenoxy-Gamma Carboline Derivatives
11/13/2008US20080280926 Phosphodiesterase Inhibitors
11/13/2008US20080280918 phosphodiesterase enzyme inhibitor; 4-[(3-chlorophenyl)amino]-2-ethyl-5-(1-hydroxyethyl)-6-phenylpyridazin-3(2H)-one; potent antiinflammatory agent; asthma, atopic dermatitis, psoriasis, chronic obstructive pulmonary disease, rheumatoid arthritis, irritable bowel disease
11/13/2008US20080280911 Cinnoline Compounds as Inhibitors of Phosphodiesterase Type IV (Pde4)
11/13/2008US20080280909 New phenylalanine derivatives
11/13/2008US20080280897 Aerosol Formulation for Inhalation
11/13/2008US20080280883 Muscarinic Receptor Antagonists
11/13/2008US20080280871 5-Phenyl-4-Methyl-Thiazol-2-Yl-Amine Derivatives as Inhibitors of Phosphatidylin Ositol 3 Kinase Enzymes (PI13) For Treatment of Inflammatory Diseases
11/13/2008US20080280863 Concurrent administering by mouth a corticosteroid and tricyclic antidepressant compound; immunoinflamamtory disorders; antiarthritic agents; skin disorders; inflammatory bowel disorders; Crohn's disorders; autoimmune disease; asthma; multiple sclerosis; diabetes; lupus
11/13/2008US20080280840 Meloxicam for the treatment of respiratory diseases in pigs
11/13/2008US20080280308 G protein coupled receptor signaling modulation
11/13/2008US20080279948 Treatment of Asthma and Copd Using Triple-Combination Therapy
11/13/2008US20080279929 Nanoparticulate and Controlled Release Compositions Comprising Cefditoren
11/13/2008US20080279856 Using heparin-binding protein specific monoclonal antibody to decrease nonapeptide separation; prevention and treatment of inflammation
11/13/2008US20080279852 Methods of treatment with glycosylated antibodies
11/13/2008US20080279841 Novel Therapeutic Molecular Variants And Uses Thereof
11/13/2008US20080279839 Composition With a Fungal (Yeast) Lipase and Method For Treating Lipid Malabsorption in Cystic Fibrous as Well as People Suffering From Pancreatic Lipase Insufficiency
11/13/2008US20080279822 Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand
11/13/2008US20080279789 Synergistic mixture; prophylaxis and treatment of respiratory system disorders
11/13/2008CA2685723A1 Morphinan compounds
11/13/2008CA2685546A1 Organic compounds
11/13/2008CA2685215A1 Compounds and methods useful for treating asthma and allergic inflammation
11/13/2008CA2684703A1 Bicyclic compound and pharmaceutical use thereof
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1990341A1 Triazolyl tropane derivatives as CCR5 modulators
11/12/2008EP1990049A2 Combination therapy of beta-blockers and non-steroidal anti-inflammatory drugs (NSAID)
11/12/2008EP1989200A2 [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases
11/12/2008EP1988916A1 Methods and agents for reducing oxidative stress
11/12/2008EP1988915A1 A method of modulating cellular activity and agents for use therein
11/12/2008EP1988892A2 Modulators of muscarinic receptors
11/12/2008EP1841768B1 Purine derivatives acting as a2a receptor agonists
11/12/2008EP1644340B1 N-[({'4-substituted piperazine-1-yl}sulfonylmethyl)alkyl]-n-hydroxyformamide compounds as metalloproteinase inhibitors
11/12/2008EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
11/12/2008EP1444349B1 Polypeptides of moraxella (branhamella) catarrhalis
11/12/2008EP1392831B1 Moraxella(branhamella) catarrhalis antigens
11/12/2008EP1259615B1 Antibodies against eotaxin and their use
11/12/2008CN101305005A Novel diazaspiroalkanes and their use for treatment of CCR8 mediated diseases
11/12/2008CN101305001A Indolizine derivatives as ligands of the CRTH2 receptor
11/12/2008CN101304985A Thiazole compounds and their use as PGD2 antagonists
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302221A Anti-platelet activating factor compound
11/12/2008CN101301475A Peg化因子vii糖型 Peg factor vii sugar type
11/12/2008CN101301463A Chinese medicinal composition for treating chronic purulent nasosinusitis and chronic rhinitis
11/12/2008CN101301459A Medicated pillow
11/12/2008CN101301446A Oral Chinese medicine for treating cough due to pathogenic wind-cold
11/12/2008CN101301443A Decoction for treating phlegm-fire cough
11/12/2008CN101301426A Medicament for treating pharyngitis
11/12/2008CN101301416A Decoction for treating chincough
11/12/2008CN101301403A Clerodendrum bungei extract and use thereof for treating airway hyperreactivity
11/12/2008CN101301397A Chinese medicine for curing rhinitis
11/12/2008CN101301385A Quality control method of compound preserved snake gall orange peel powder
11/12/2008CN101301383A Quality control method of formulation for clearing wind-heat of children
11/12/2008CN101301378A Medicament for relieving cough and moistening lung
11/12/2008CN101301362A Externally used medicament composition for treating allergic asthma
11/12/2008CN101301361A Double coptis medicinal sweet for upper respiratory tract infection of children
11/12/2008CN101301359A Bitong capsule and preparation thereof
11/12/2008CN101301355A Oil composition containing 1,8-cineole and flavanones extracted from Litsea lancilimba Merr. and Blumea Balsamifera DC. And use thereof
11/12/2008CN101301338A Oral Chinese medicine for treating asthma and cough
11/12/2008CN101301331A Oral liquid for relieving cough and preparation thereof
11/12/2008CN101301291A Compound enrofloxacin injection for animals and preparation thereof
11/12/2008CN101301110A Health cigarette
11/12/2008CN101301083A Ginger tea capable of preventing and treating common cold
11/12/2008CN101301081A Horseradish tree chawing tablet
11/12/2008CN100432070C Novel sulfamides and their use as endothelin receptor antagonists
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/12/2008CN100432047C Synthesis process of peramivir as medicine for antagonizing influenza and bird flu virus
11/12/2008CN100431604C C1 inhibitor with short half-life for transient treatment
11/12/2008CN100431598C Chinese medicine plaster for treating asthma and preparing method
11/12/2008CN100431590C Chinese medicinal composition for treating cough and asthma
11/12/2008CN100431583C A Chinese proprietary medicine for mainly treating bronchitis and asthma and method for preparing same
11/12/2008CN100431572C Application of Kudancao in use for resisting lung fibrosis
11/12/2008CN100431559C Medicine for treating common cold and its preparing method
11/12/2008CN100431535C Chlorhydric acid tranditerol aerosol
11/12/2008CN100431516C Device for calculating elixir doses approprate for patient's weight
11/11/2008US7449581 6-Substituted pyrido-pyrimidines
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449492 Therapeutic agents—I
11/11/2008US7449475 e.g. 2-{[(2S)-3-(5-Chloro-1'H,3H-spiro[1-benzofuran-2,4'-piperidin]-1'-yl)-2-hydroxypropyl]oxy}-N-cyclopropylbenzamide; macrophage inflammatory protein (MIP)-1 alpha chemokine receptor modulator; antiinflammatory, antiproliferative agent, autoimmune diseases
11/11/2008US7449473 8-(1-methyl-1H-pyrrol-2-yl)-1,3-dipropyl-1H-pyrrolo[3,2-d]pyrimidine-2,6-dione; asthma, chronic obstructive pulmonary disorder, emphysema, diabetic disorders, inflammatory gastrointestinal tract disorders, immunological/inflammatory disorders, cardiovascular diseases, neurological disorders
11/11/2008US7449472 Methods of inhibiting p38 with substituted bicyclic pyrimidines
11/11/2008US7449470 Antagonists to treat neurodegenerative diseases like Parkinson's disease; 2,4,6-trisubstituted pyrimidines; N-(2,6-diphenyl-pyrimidin-4-yl)-benzamide
11/11/2008US7449456 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
11/11/2008US7449446 Synergistic mixture; anticoagulants
11/11/2008US7449324 Determining in a sample of an animal the presence of a viral component by reacting the sample with a nucleic acid or an antibody reactive with component of an avian pneumovirus, and crossreactive with a component of MPV (metapneumovirus)
11/11/2008US7449201 Storage stable power compositions of interleukin-4 receptor
11/06/2008WO2008134547A1 Methods of using hydroxycyclohexane and hydroxypiperidine compounds in treating sodium channel-mediated diseases or conditions
11/06/2008WO2008133900A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists
11/06/2008WO2008133330A1 Stable solid preparation comprising 4,5-epoxymorphinan derivative
11/06/2008WO2008131922A1 New 4,8-diphenyl-polyazanaphthalene derivatives
11/06/2008WO2008131859A2 Use of cyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia
11/06/2008WO2008131858A2 Use of acyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia
11/06/2008WO2008131586A1 Uses of 5-methyl-1-(substituted phenyl)-2(1h)-pyridones as anti-inflammatory and tnf-alpha-blocking agents
11/06/2008WO2008094976A3 Use of estrogen receptor beta selective ligands for treating acute lung injuries
11/06/2008WO2008084312A3 Micronised particles of low-dosage strength active agents for powder formulations for inhalation
11/06/2008WO2008073933A3 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
11/06/2008WO2008009476A3 Concentrated methotrexate solutions
1 ... 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 ... 878